Literature DB >> 33309045

[Influenza vaccination in the time of SARS-CoV-2].

Jordi Reina1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33309045     DOI: 10.1016/j.medcli.2020.10.012

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


× No keyword cloud information.
  4 in total

1.  Association between Influenza Vaccination and Positive SARS-CoV-2 IgG and IgM Tests in the General Population of Katowice Region, Poland.

Authors:  Małgorzata Kowalska; Ewa Niewiadomska; Kamil Barański; Angelina Kaleta-Pilarska; Grzegorz Brożek; Jan Eugeniusz Zejda
Journal:  Vaccines (Basel)       Date:  2021-04-21

2.  Dynamics of specific antibodies in COVID-19 patients after recovery.

Authors:  Zhi-Bo Deng; Feng Cheng; Yong Zhang
Journal:  Epidemiol Infect       Date:  2022-03-22       Impact factor: 2.451

3.  Epidemiologic Profile of Severe Acute Respiratory Infection in Brazil During the COVID-19 Pandemic: An Epidemiological Study.

Authors:  Nathália Mariana Santos Sansone; Matheus Negri Boschiero; Fernando Augusto Lima Marson
Journal:  Front Microbiol       Date:  2022-07-01       Impact factor: 6.064

4.  Effect and Tolerability of a Nutritional Supplement Based on a Synergistic Combination of β-Glucans and Selenium- and Zinc-Enriched Saccharomyces cerevisiae (ABB C1®) in Volunteers Receiving the Influenza or the COVID-19 Vaccine: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Julián Andrés Mateus Rodriguez; Mónica Bifano; Elvira Roca Goma; Carlos Méndez Plasencia; Anna Olivé Torralba; Mercè Santó Font; Pedro Roy Millán
Journal:  Nutrients       Date:  2021-12-02       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.